ICD-10-CM Diagnosis Code (2025)
Official Description for D75.81
Myelofibrosis
Coding Notes & Guidelines for D75.81
- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
code for adverse effect, if applicable, to identify drug (T45.1X5)
- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Parent Code (Less Specific):
About ICD-10-CM Code D75.81 (Myelofibrosis)
ICD-10-CM code D75.81 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM D75.81 became effective on October 1, 2024.
This page provides detailed information about D75.81 - Myelofibrosis. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Myelofibrosis.